Shares in Novocure (NSDQ:NVCR) fell slightly today after the medical device maker missed expectations on Wall Street with its fourth quarter and full year 2018 earnings release.
The St. Helier, Jersey-based company posted losses of $15.6 million, or 17¢ per share, on sales of $69.7 million for the three months ended December 31, seeing losses grow 42.8% while sales grew 29.8% compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business News
The post Novocure shares dip on Q4, 2018 earnings miss appeared first on MassDevice.
from MassDevice https://ift.tt/2ThXzwB
Cap comentari:
Publica un comentari a l'entrada